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INTRODUCTION
Recent discussions about the physician workforce have
focused on the shortage of primary care physicians in the
United States [1–3]. The Federated Council for Internal
Medicine, the American College of Physicians, and the
Association of Professors of Medicine have advocated a goal
of 50% of internal medicine residents choosing a career in
primary care [4–5]. Accordingly, medical training programs
have changed their emphasis to provide more education in
primary care and less in subspecialty areas [6].
In addition, downsizing (i.e., reducing the number of
internal medicine residency positions that are offered in the
United States) has been suggested as a way to overcome the
various concerns facing internal medicine. As reported in the
general medical literature, these concerns include a predicted
oversupply of doctors, the growth of specialization, the rising
cost of medical treatments, and perhaps a lack of interest in
internal medicine careers [7]. Many academic centers are
using nonphysicians to compensate for the reduced availabil-
ity of internal medicine residents. Some states have mandat-
ed reduced hours that residents are allowed to work [8].
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ABSTRACT
Personnel involved in supportive care of bone marrow transplant (BMT) patients include fellows (F), medical
house-staff (HS), nurse practitioners (NP), physician assistants (PA), and moonlighting physicians (MP). We have
obtained surveys from 108 American and Canadian transplant centers on the composition of inpatient support
teams. Eighty-seven percent of institutions responding to the survey were university-based programs. Eighty-eight
percent of the centers performed both allogeneic and autologous transplants, and 60% performed unrelated donor
grafts. The mean number of transplants performed annually at each center was 101 (range 4–515). For daytime cov-
erage, the percent of programs involving F, HS, NP, PA, or MP was 57, 50, 35, 25, and 0%, respectively, and for
nighttime coverage, the composition was 50, 56, 7, 6, and 13%, respectively. Medical HS were incorporated into the
care of BMT patients at some level in 93% of the programs. Involvement by HS included full 24-hour coverage
(44%), full nighttime coverage (8%), stat coverage (18%), and code blue only coverage (21%). HS involvement was
similar in small and large transplant programs. HS were more involved in university-based programs. Programs on
the East Coast had more HS involvement, with 54% of the programs reporting full 24-hour coverage by HS com-
pared with 32% of the programs in the Pacific region. Coverage of transplant patients varies throughout the coun-
try, and nonphysician providers are often used. HS are more active in university-based programs, and their role is
similar in both large and small programs.
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Some studies have suggested that a mid-level practition-
er, such as a physician assistant or nurse practitioner, could
perform some duties of a resident (information gathering,
documentation, and coordination of care) [9]. In 1994, the
American College of Physicians policy for physicians, nurse
practitioners, and physician assistants outlined a highly col-
laborative role for all professionals and included “expanded
roles for nurse practitioners and physician assistants working
in hospitals and ambulatory settings as substitutes for physi-
cian house staff ” [10].
Each year, 10,000 patients undergo allogeneic bone
marrow transplantation (BMT) for leukemia, lymphoma,
genetic diseases, and a variety of other hematologic disor-
ders. For most of these patients, BMT is the only curative
option [11]. Another 9000 patients search for an unrelated
bone marrow donor [12].
Traditionally, these transplantation procedures have
resulted in prolonged hospitalizations requiring an acute
level of care and a dedicated staff. Although allogeneic
transplants are expensive, costing up to $100,000 per proce-
dure, BMT is more cost-effective in treating some diseases
than is conventional chemotherapy [13]. The cost per addi-
tional year of life saved by allogeneic transplant for acute
myelogenous leukemia in ﬁrst remission is $10,000. By con-
trast, the cost per additional year of life saved by the treat-
ment for moderate hypertension is $14,000 [13].
The number of transplants performed each year contin-
ues to grow. The International Bone Marrow Transplant
Registry/Autologous Bone Marrow Transplant Registry
(IBMTR/ABMTR) estimated that 12,000 allogeneic and
18,000 autologous transplants were performed worldwide in
1995 [14]. In 1990, the estimate had been 6000 allogeneic
and 2000 autologous transplants [14].
The use of transplant in metastatic and high-risk breast
cancer has increased dramatically the number of autologous
transplants performed each year [15,16]. Also, growth fac-
tors and better supportive care promote the use of this
modality in non–university-based settings [15].
We conducted a survey of transplant centers in the
United States and Canada to determine the level of houses-
taff involvement and the use of nonphysician care providers.
We examined the role of hematology/oncology fellows
(physicians who have completed their residency in internal
medicine and are training in hematology or oncology),
housestaff (physicians in a 3-year internal medicine training
program), nurse practitioners (nurses with advanced training
who are working under the supervision of an attending
physician), and physician assistants (skilled health profes-
sionals who complete a 2-year training program and work
under the license and supervision of an attending physician).
MATERIALS AND METHODS
A questionnaire was sent to 152 institutions registered
as members of the American Society for Blood and Marrow
Transplantation (ASBMT). Centers in the United States and
Canada only were included because they represent the
majority of members in the ASBMT and because of their
similarity in training programs. One hundred eight institu-
tions responded; nine were located in Canada and 99 in the
United States, representing 34 different states. The survey
specifically asked about coverage of BMT inpatients and
consisted of four questions.
1. Who provides primary daytime coverage for BMT 
patients? (Circle one or more choices.)
a. Attending
b. Fellow
c. Physician assistant
d. Nurse practitioner
e. Housestaff
f. Other
2. Who provides primary nighttime/weekend coverage 
for BMT patients? (Circle one or more choices.)
a. Attending
b. Fellow
c. Physician assistant
d. Nurse practitioner 
e. Housestaff 
f. Moonlighting physician
g. Other
3. What is the role of the medicine housestaff? (Circle 
only one choice.)
a. Provides emergency coverage only (code blue, etc.)
b. Provides stat coverage (seizures, sudden hyperten-
sion, chest pain, and respiratory insufﬁciency)
c. Provides full nighttime coverage
d. Provides full 24-hour coverage
e. Other
4. List the type of transplants that are performed at your
center?
Centers were asked to list the number of adult and
pediatric transplants performed each year and to specify
autologous, related allogeneic, or unrelated allogeneic.
Cord blood transplants were included with the unrelated
allogeneic transplants.
Statistical analysis
Data were analyzed by the Medlog program for data-
base management and analysis. To test for signiﬁcant differ-
ences in proportions of a response item, chi-square statistics
were calculated [17]. If any expected cell value was 5, Fish-
er’s exact test was applied [17]. p is two-sided and the level of
statistical signiﬁcance is 0.05.
RESULTS
The mean number of transplants performed annually at
each institution was 101 (range 4–515). The median num-
ber was 74, which consisted of 58 adult autologous trans-
plants (range 0–350), 21 adult allogeneic transplants (range
0–160), and eight adult unrelated donor transplants (range
0–94). Fifty-four percent of the institutions reported having
performed at least one pediatric transplant. The mean num-
ber of pediatric transplants performed at the institutions was
5 autologous (range 0–80), 5 allogeneic (range 0–35), and 4
unrelated donor transplants (range 0–49).
Of the responding institutions, 12% performed autolo-
gous transplants only and 88% performed both autologous
and related allogeneic transplants (Fig. 1). Sixty percent per-
formed unrelated donor transplants. Eighty-seven percent
of the responding institutions were university-based pro-
grams. All of these institutions had a medical residency pro-
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gram or were affiliated with a hospital that had a medical
residency training program.
Who provides primary daytime coverage of BMT patients?
In response to the query regarding primary daytime
coverage of BMT patients, 57% of the programs reported
that a fellow provided this service, 50% housestaff, 35%
nurse practitioner, and 25% physician assistant. Institutions
were permitted to check more than one category for this
question, according to the coverage in their institution. We
assumed that attending physicians at all institutions were
involved in patient care.
Who provides primary nighttime coverage of BMT patients?
Primary nighttime coverage was provided by a fellow in
50% of the programs, the housestaff in 56%, a nurse practi-
tioner in 7%, and a physician assistant in 6%. Moonlighting
physicians were used by 13% of BMT programs.
Who made up the moonlighting physician group (hous-
estaff, fellows, etc.) was not determined. Again, it was
assumed that the attending physicians at each institution
were involved in some aspect of patient care. The survey
did not question whether care was delivered from in hospi-
tal or from home.
What is the role of the medicine housestaff?
BMT programs reported that the housestaff had no
involvement (7%) in caring for patients, emergency only (i.e.,
cardiopulmonary arrest code blue; 21%), or stat only (i.e.,
seizures, sudden hypotension, chest pain, or respiratory insuf-
ﬁciency; 18%) (Fig. 2). Eight percent of the programs report-
ed having only full nighttime coverage and 44% full 24-hour
coverage, i.e., 52% of programs had nighttime coverage by
housestaff. Two percent of programs chose “other.” Institu-
tions could mark only one choice in answer to this question.
We next studied whether geographical location, number
of transplants performed, type of transplant program, or
managed care penetration had any effect on the level of
housestaff involvement. The number of annual transplants
performed were divided by quartiles: 45, 45–74, 75–124,
and 125 transplants. When comparing large and small
programs, we noted no difference in housestaff involvement
(Table 1). Table 2 shows the role performed by the house-
staff based on the type of BMT program, whether universi-
ty-based or private practice–based. Private practice pro-
grams had only 21% of full 24-hour involvement by house-
staff; university programs had 47%. This difference was not
statistically signiﬁcant ( p  0.07).
The level of housestaff involvement varied somewhat
according to the type of transplants performed. Of institu-
tions performing unrelated donor transplantations, 50%
reported full 24-hour coverage by housestaff. In contrast,
only 33% of those not performing unrelated donor trans-
plantations reported the same level of coverage. The differ-
ence between these two did not, however, reach statistical
significance ( p  0.07). Eleven percent of the institutions
that performed unrelated donor BMT had no in-hospital
physician coverage (either fellow or housestaff).
We next compared nine Canadian transplant programs
with 99 American ones. The level of housestaff involve-
ment was similar in the two countries. All Canadian pro-
grams were university-based and 44% used housestaff for
Figure 1. Percent of institutions that performed autologous transplants only, autologous and related allogeneic only, or autologous, related
allogeneic, and unrelated donor transplants
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full 24-hour coverage. In the United States, 86% of the
programs were university-based and 43% had full 24-hour
housestaff involvement.
Finally, we studied the role of housestaff by geographi-
cal location, based on time zones: Pacific, mountain, cen-
tral, and eastern (Table 3). Programs in Hawaii were
included with the Pacific programs. We found that pro-
grams located in the Pacific, mountain, and central time
zones had similar proportions of full 24-hour housestaff
coverage; 32, 20, and 37%, respectively ( p  0.75). Fifty-
four programs located in the eastern zone, however, had a
higher proportion (54%) of 24-hour coverage than did 54
non-eastern programs (33%, p  0.03).
Because of this intriguing difference based on location,
we studied whether health maintenance organization
(HMO) penetration affected coverage of BMT patients.
Table 4 shows the level of housestaff involvement in the
United States, which is separated into eight geographic
regions on the basis of HMO penetration [18]. Data were
obtained from the Managed Care Digest series and show the
affects of penetration for a speciﬁc geographic area, but do
not reﬂect penetration based on a speciﬁc transplant center
that was surveyed. Among the 99 U.S. institutions, the pro-
portion with full 24-hour housestaff involvement did not
vary significantly by HMO penetration ( p  0.18). The
geographical differences in coverage, therefore, cannot be
explained by HMO penetration. 
DISCUSSION
In a survey of 108 institutions, we have shown that hous-
estaff are involved in the care of BMT patients in 93% of
Figure 2. Role of housestaff in each institution
The percent of institutions ranking each response are noted on the graph.
Table 2. Role of housestaff by program (%)
University Private practice
No involvement 4 29
Emergency only 21 21
STAT 17 21
Full nighttime 9 7
Full 24-hour 47 21
Other 2 0
Table 1. Role of housestaff by total number of transplants performed (%)
Quartile
40 40–74 75–124 125
No involvement 12 4 7 7
Emergency only 19 33 19 15
STAT 23 4 26 19
Full nighttime 4 7 11 11
Full 24-hour 38 48 37 48
Other 4 4 0 0
By quartile n26 n27 n27 n27
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reporting programs. Nonphysician providers are used fre-
quently, especially nurse practitioners and physician assis-
tants. Housestaff are more active in university-based trans-
plant programs, although this difference did not reach statis-
tical signiﬁcance. All university-based programs studied were
afﬁliated with an accredited medical residency program. The
role of housestaff was similar among the programs, regardless
of the number of transplants annually performed.
Programs located in the eastern United States had more
housestaff involvement than did those in the Paciﬁc region.
We found no significant connection between the level of
coverage and the degrees of managed care penetration [19,
20]. Because all reporting programs were members of the
ASBMT, this study may be somewhat biased. 
The role of housestaff and the use of nonphysician
providers in the BMT setting has not been studied previously.
In 1994, a retrospective chart review compared the patient
care delivered by nurse practitioners and physician assistants
with that by pediatric residents in the neonatal intensive care
unit (NICU). The study reviewed 244 consecutive admissions
to a NICU in Florida. Patients were cared for by one of two
teams: one staffed by residents, the other by neonatal nurse
practitioners and physician assistants. Team performance was
assessed by comparing patient management outcome and fees
charged by both the hospital and the physicians. The results
showed no difference in patient outcome whether patients
were cared for either by the neonatal nurse practitioners and
physician assistants or by the NICU residents [21].
In the ﬁeld of oncology, however, there have been few
reports on the use of housestaff, nonphysician extenders, or
other methods of patient coverage [22]. One recent study
on cancer screening compared nurse practitioner interven-
tion at one site with the physician reminder system at a
control site. Baseline annual screening rates were compara-
ble for the two groups. At the end of the study, however,
screening rates were signiﬁcantly higher at the nurse practi-
tioner site. (It was noted that the screening population,
low-income African American women 65 years old,
remained below screening levels targeted by the National
Cancer Institute [23].) A large comprehensive cancer
screening activity by mid-level providers is being utilized
by the Mofﬁtt Cancer Center’s Lifetime Cancer Screening
Program in Tampa, Florida [22].
An analysis of transplant outcomes based on type of cov-
erage would be intriguing. Given the variety of patients, dis-
ease types and stages, conditioning regimens, and supportive
care approaches, the data are extremely difficult to obtain
and to correlate fairly. Different coverage patterns include
coverage by physicians-in-training (housestaff and fellows),
nurse practitioners, physician assistants, or attendings alone.
No consistent pattern emerges for a minimum level of cov-
erage. To date, there are no set standards for the minimal
level of coverage, and from this report we are unable to
determine the best or an acceptable level of coverage.
Although the indications for BMT are increasing and more
hospitals are adding BMT programs, housestaff involvement
may be reduced because of ﬁnancial pressures and mandated
training patterns and hours. The role of housestaff will cer-
tainly be evolving as economic issues change and additional
patterns of medical coverage are added. We hope to repeat
this study in ﬁve years.
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The following institutions kindly responded to our survey:
All Childrens Hospital, St. Petersburg, FL; M.D. Anderson
Cancer Center, Houston, TX; Baylor University Medical
Center, Dallas, TX; Beth Israel Hospital, Boston, MA;
Boyce and Bynum Pathology Professional Services, Colum-
bia, MO; British Columbia Children’s Hospital, Vancouver,
BC, Canada; Brooke Army Medical Center, San Antonio,
TX; Children’s Hospital Medical Center, Cincinnati, OH;
Children’s Hospital of Los Angeles, Los Angeles, CA; Chil-
dren’s Hospital of Orange County, Orange, CA; City of
Table 3. Role of housestaff by program location (%)
Pacific Mountain Central Eastern
No involvement 26 20 7 0
Emergency 21 40 27 17
Stat 16 0 20 19
Full nighttime 5 20 7 9
Full 24-hour 32 20 37 54
Other 0 0 3 2
n=19 n=5 n=30 n=54
Table 4. Role of housestaff by region and HMO penetration in the United States (%)
Pacific New England Mountain Mid-Atlantic East–North Central West–North Central South Atlantic South Central
(0.358)a (0.300) (0.240) (0.238) (0.196) (0.183) (0.147) (0.109)
No involvement 24 0 25 0 0 29 0 7
Emergency 24 25 50 7 16 43 20 21
Stat 12 13 0 20 21 0 27 29
Full nighttime 6 0 25 7 16 0 0 7
Full 24-hours 35 63 05 67 47 29 47 29
Other 0 0 0 0 0 0 7 7
n17 n8 n34 n15 n19 n7 n15 n14
aHMO penetration rate (national average  0.211).
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Hope National Medical Center, Duarte, CA; Cleveland
Clinic, Cleveland, OH; Columbia Presbyterian Medical
Center, New York, NY; Dana Farber Cancer Institute,
Boston, MA; Dartmouth Hitchcock Medical Center,
Lebanon, NH; Duke University Medical Center, Durham,
NC; Eggleston Children’s Hospital, Atlanta, GA; Emory
University School of Medicine, Atlanta, GA; John R. Fea-
gler, MD, Omaha, NE; Georgetown University, Washing-
ton, DC; Hackensack Medical Center, Hackensack, NJ;
Hahnemann University, Philadelphia, PA; Harper Hospital,
Detroit, MI; Health Sciences Center, Winnipeg, MB, Cana-
da; Houston Cancer Institute, Houston, TX; Fred Hutchin-
son Cancer Research Center, Seattle, WA; Johns Hopkins
Hospital, Baltimore, MD; Kaiser Permanente, Los Angeles,
CA; Kansas University Medical Center, Kansas City, KS;
Latter Day Saints Hospital, Salt Lake City, UT; Loyola
University Medical Center, Maywood, IL; Lutheran Gener-
al Hospital, Park Ridge, IL; Massachusetts General Hospi-
tal, Boston, MA; Mayo Clinic, Rochester, MN; Medical
Center of Delaware, Newark, DE; Medical College of Vir-
ginia, Richmond, VA; Medical College of Wisconsin, Mil-
waukee, WI; Medical Oncology and Hematology, Berkeley,
CA; Medical University of South Carolina, Charleston, SC;
Memorial Sloan Kettering Cancer Center, New York, NY;
Methodist Hospital of Indiana, Indianapolis, IN; H. Lee
Mofﬁtt Cancer Center and Research Institute, Tampa, FL;
Montefiore University Hospital, Pittsburgh, PA; Montreal
General Hospital, Montreal, QC, Canada; Mount Sinai
Hospital, New York, NY; National Marrow Donor Pro-
gram, Minneapolis, MN; New York Hospital, Valhalla, NY;
New York Medical College, New York, NY; Norris Cancer
Hospital and Research Institute, Los Angeles, CA; North
Shore University Hospital, Manhassett, NY; North Subur-
ban Medical Consultants, Park Ridge, IL; Northwestern
University Medical School, Chicago, IL; Oncology Clinic,
Houston, TX; Ohio State University, Columbus, OH;
Ontario Cancer Institute, Ottawa, ON, Canada; Ottawa
General Hospital, Ottawa, ON, Canada; Pediatric Faculty
Foundation, Chicago, IL; Rainbow Babies and Children’s
Hospital, Cleveland, OH; Michael Reese Hospital, Chicago,
IL; Roswell Park Cancer Institute, Buffalo, NY; Royal Vic-
toria Hospital, Montreal, QC, Canada; Rush-Presbyterial-
St. Luke’s Medical Center, Chicago, IL; St. Joseph’s Hospi-
tal, Orange, CA; St. Joseph’s Hospital, Marshﬁeld, WI; St.
Jude Children’s Research Hospital, Memphis, TN; Scripps
Clinic and Research Foundation, La Jolla, CA; South Texas
Cancer Institute, San Antonio, TX; Stanford University,
Stanford, CA; Stem Cell Sciences, New York, NY; SUNY-
Health Science Center, Syracuse, NY; Surgical Associates,
Honolulu, HI; Sutter Cancer Center, Sacramento, CA;
Temple University Cancer Center, Philadelphia, PA; Texas
Children’s Hospital, Houston, TX; The Chicago Medical
School, Chicago, IL; The Methodist Hospital, Houston,
TX; Tulane Cancer Center, New Orleans, LA; University
Hospital and London Regional Cancer Center, London,
ON, Canada; University Hospitals of Cleveland, Cleveland,
OH; University of Alabama, Birmingham, AL; University of
Arizona, Tucson, AZ; University of Arkansas, Little Rock,
AR; University of Calgary, Calgary, AB, Canada; University
of California, Los Angeles, Los Angeles, CA; University of
California, San Diego, San Diego, CA; University of Cali-
fornia, San Francisco, San Francisco, CA; University of
Colorado Health Sciences Center, Denver, CO; University
of Connecticut Medical Center, Farmington, CT; Universi-
ty of Hawaii, Honolulu, HI; University of Kentucky,
Louisville, KY; University of Maryland Cancer Center, Bal-
timore, MD; University of Massachusetts, Worcester, MA;
University of Miami School of Medicine, Miami, FL; Uni-
versity of Michigan, Ann Arbor, MI; University of Minneso-
ta, Minneapolis, MN; University of Missouri, Columbia,
MO; University of Nebraska Medical Center, Omaha, NE;
University of North Carolina, Chapel Hill, Chapel Hill,
NC; University of Oklahoma Health Sciences Center,
Oklahoma City, OK; University of Pennsylvania Medical
Center, Philadelphia, PA; University of Rochester Medical
Center, Rochester, NY; University of South Carolina,
Columbia, SC; University of Toronto, Toronto, ON, Cana-
da; University of Utah Medical Center, Salt Lake City, UT;
Vanderbilt University, Nashville, TN; Joseph D. Verdirame,
M.D., Omaha, Nebraska; Wake Forest University Compre-
hensive Cancer Center, Winston-Salem, NC; Western
Pennsylvania Hospital, Pittsburgh, PA; West Virginia Uni-
versity, Morgantown, WV; Roger Williams General Hospi-
tal, Providence, RI.
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